Dr. Philip M. Arlen gives keynote address on NEO-201 Developments at World Antibody Congress, San Diego, CA, March 20th, 2023

Dr. Philip M. Arlen, President and CEO, Precision Biologics, gives keynote address entitled “Preclinical/Clinical Development of a Neo-epitope targeted Monoclonal Antibody for Cancer therapy” at World Antibody Congress, San Diego, CA, March 20th, 2023, 9:10am, during Festival of Biologics scientific conference, Sheraton San Diego Hotel & Marina.